Previous Page
20
nanotimes
Companies Facts
of Dye Solar Cell (DSC) materials and technology, has raised a total of AUD $5 million, through take-up by shareholders of the recent Share Purchase Plan and a supplementary placement to sophisticated investors. The transaction was partly underwritten by Octa Phillip Securities for a total of $3 million and, consequently, there was no shortfall to the under- writer. In addition to the approximate $3.9 million of proceeds raised from the Share Purchase Plan, the Company has also placed $1.1 million in shares at 18 cents per share to sophisticated investors, comprised principally of existing sophisticated investor sharehol- ders. The total number of shares to be issued will be approximately 27.78 million.
A
“The Company is deeply gratified by the strong financial support from Dyesol shareholders and looks forward to reporting exciting developments in our world-class partner projects in the coming weeks and months.” Dyesol Chairman Richard Caldwell stated.
Moreover, Dyesol has ended the engagement of Dr. Gavin Tulloch. Dr. Tulloch has performed as a consultant in the role of Director of Technology since October 2010 and he will cease performing that role immediately. He will remain a non-executive direc- tor of the Company.
he third 1.6m production line Nanospider™ of Elmarco, a leading seller and supplier of indus-
trial scale nanofiber production equipment, has been bought by the same customer. The third or-
F
ustralian company Dyesol Limited (ASX: DYE, OTCQX: DYSOY FSE: D5I.F), a global supplier
dered production line NS 8S1600U, which is worth just under 40 million CZK ($2.16 million), consists of two electrospinning units 1.6m wide, just as the first two already installed lines. The final production capacity proves the fast increase of nanofiber pro- ducts demand, because the nanofiber production equipment demand sensitively reflects to nanofiber products just on final markets. The good news for the nanofiber industry is, that the final consumer perci- ves the added value of nanofibers and products with integrated nanofibers are prefered. According to the contract from March 2012, production line should be installed till the end of this year. The customer is a company from the Middle East, which is signifi- cant supplier of products and services for industrial filtration.
mefcy‘s Electrogenic Bioreactor (EBR) treats wastewater and produces green electricity as a
byproduct. The EBR functions as a battery which uses wastewater as fuel. With its Spiral Aerobic Reactor (SABRE) Emefcy changes the economics of wastewa- ter treatment while reducing energy consumption dramatically and also reducing the amount of excess sludge. The SABRE is a passive-aeration treatment process.
lamel Technologies (NASDAQ: FLML) announced the acquisition of Éclat Pharmaceuticals, a spe-
cialty pharmaceutical company that is focused on the development, approval, and commercialization
12-03 :: March/April 2012